Recent studies from UTHealth Houston and the University of California, Irvine (UCI) have provided new insights into the genetic mechanisms underlying Alzheimer's disease. Researchers at UTHealth Houston identified specific gene disruptions and regulatory malfunctions within brain regions affected by sporadic early onset Alzheimer's. Separately, a UCI team developed a machine learning platform, SIGNET, to map causal gene interactions across various brain cell types in Alzheimer's patients, identifying new potential targets for diagnosis and treatment.
UTHealth Houston Investigates Early Onset Alzheimer's Gene Disruptions
Researchers at UTHealth Houston, led by Zhongming Zhao, PhD, MS, investigated gene expression and regulation at single-cell levels in patients with sporadic early onset Alzheimer's disease. This form of the disease affects individuals under 65, accounts for approximately 90% of early onset cases, and its genetic basis is largely unknown. The findings were published in the journal Science Advances.
The study utilized advanced single-nucleus multiomics techniques to analyze over 76,000 cell nuclei from three brain regions critical to Alzheimer's progression: the prefrontal cortex, entorhinal cortex, and hippocampus. This approach provided a detailed view of molecular signals and gene regulations across these regions, a comparison not previously conducted in this disease context.
Key Findings:
- The most severe gene disruptions were identified within the entorhinal cortex and hippocampus, which are symptomatically involved in sporadic early onset Alzheimer's disease.
- Malfunctions were found in specific gene regulators, or 'switches,' including RFX4 in astrocytes (support cells) and IKZF1 in microglia (brain immune cells).
- These regulators influence genes controlling brain cell communication and the brain's immune system response.
- Cell pathways involved in neuroinflammation and neuronal communication junctions showed alterations in the presence of Alzheimer's pathogens.
- The research also examined glial cells and astrocytes, noting astrocytes' role in inflammation and potential for unintended damage to brain cells when responding to amyloid plaques.
While some findings aligned with late-onset Alzheimer's disease progression, the study noted unique patterns in sporadic early onset Alzheimer's, including shared vulnerabilities with conditions such as schizophrenia and bipolar disorder.
Researchers suggest these findings could point to potential therapeutic targets aimed at restoring normal gene regulation and intercellular communication, informing future research and precision medicine approaches.
UC Irvine Develops Tool to Map Causal Gene Regulation
A separate research team at the University of California, Irvine (UCI), led by Min Zhang and Dabao Zhang, developed a machine learning platform called SIGNET to create detailed maps of causal gene interactions within brain cells affected by Alzheimer's disease.
This work aimed to move beyond identifying correlations to uncover cause-and-effect relationships between genes, potentially revealing biological pathways contributing to memory loss and brain tissue breakdown.
The study was published in Alzheimer's & Dementia: The Journal of the Alzheimer's Association.
SIGNET integrates single-cell RNA sequencing with whole-genome sequencing data from brain samples of 272 participants in long-term aging studies, specifically the Religious Orders Study and the Rush Memory and Aging Project. This integration enabled the construction of causal gene regulatory networks for six major brain cell types, identifying genes likely directing the activity of others.
Key Findings:
- Significant gene disruptions were observed in excitatory neurons, with nearly 6,000 cause-and-effect interactions indicating genetic rewiring during Alzheimer's progression.
- Hundreds of "hub genes" were identified as central regulators, influencing many other genes, suggesting their role in harmful brain changes.
- These hub genes are considered potential targets for early detection and therapeutic intervention.
- New regulatory roles were discovered for genes such as APP in inhibitory neurons.
The findings were validated using an independent set of human brain samples. Researchers stated that SIGNET may also be applicable to studying other complex diseases, including cancer, autoimmune disorders, and mental health conditions. This research was supported by funding from the National Institute on Aging and the National Cancer Institute.
Advancing Alzheimer's Research
Both studies contribute to a growing understanding of the complex genetic and molecular mechanisms of Alzheimer's disease. The UTHealth Houston study provides specific insights into the understudied sporadic early onset form, while the UCI study offers a new tool and a comprehensive mapping of causal gene regulation across different cell types in the broader context of Alzheimer's, potentially leading to new diagnostic and therapeutic strategies.